ROX Medical's FLOW procedure is a short, minimally invasive, catheter-based procedure whereby Interventional Cardiologists, Radiologists or Endovascular Specialists place a stent-like connection between the artery and vein in the upper leg. The procedure is intended to reduce peripheral vascular resistance, thereby holding the promise of a meaningful long-term reduction in hypertension. Uniquely, the FLOW procedure only involves the vascular structure, has an immediate effect; and is fully reversible.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/07/12 | $6,000,000 |
Domain Associates Versant Ventures | undisclosed | |
| 09/06/16 | $40,000,000 | Series E |
Apple Tree Partners Domain Associates Novartis Venture Funds Versant Ventures | undisclosed |
